A Novel SARS-COV-2 Variant Omicron Disseminating Evaluation

ABSTRACT

Omicron is a relatively new form of COVID-19 that has created an unavoidable and life-threatening situation to the entire world since late 2021. Absence of appropriate vaccination, medication, the epidemiological cycle has become more complex. This study primarily concentrates on the analysis of genome sequence for COVID-19 variants. To conduct such analysis, two datasets are collected from Kaggle and GISAID. Using these datasets, the globally existing genome sequences are identified and insights regarding the countries that are carrying significantly higher genome sequence count are provided. This investigation analyzes the worldwide virus variants and further identifies that the United States and United Kingdom are the countries where proper inspection should be provided because of the genome sequence count. An adequate idea regarding the mutations of the Omicron virus is also considered in this study. To address this issue, recent genome sequence data ranging from February, 2022 to 10th March, 2022 is analyzed to understand how the latest arrival, Omicron, is perturbing the world. This study emphasizes on the constant surveillance of genome sequences among all the countries which in turn will benefit the health care professionals and frontline healthcare workers as well as the Governments can take necessary policies and precautions to combat such pandemic. © 2023, The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.